Igo-ogan, Baby Girl -.
HRN: 23-59-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
CEFOTAXIME 500MG (VIAL)
09/01/2023
09/07/2023
IV
150mg
Q12hrs
Thickly MSAF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes